Ensysce Biosciences, Inc.
(NASDAQ : ENSC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%333.610.0%$4453.05m
BNTXBioNTech SE 2.55%269.560.0%$741.67m
NVAXNovavax, Inc. -15.40%135.8279.4%$601.55m
AMGNAmgen, Inc. 1.50%209.891.4%$554.53m
SNSSSunesis Pharmaceuticals, Inc. 4.81%6.440.7%$450.18m
REGNRegeneron Pharmaceuticals, Inc. 1.72%561.592.7%$438.99m
GILDGilead Sciences, Inc. 0.31%67.111.0%$414.36m
CCXIChemoCentryx, Inc. 3.34%34.782.9%$398.29m
ILMNIllumina, Inc. -0.15%413.463.3%$374.06m
XLRNAcceleron Pharma, Inc. -0.51%172.855.3%$348.53m
VRTXVertex Pharmaceuticals, Inc. 0.49%186.311.9%$271.07m
BIIBBiogen, Inc. -0.32%267.261.7%$242.74m
OCGNOcugen, Inc. 5.52%8.790.0%$186.16m
XENEXenon Pharmaceuticals, Inc. 2.05%30.420.4%$163.66m
CRSPCRISPR Therapeutics AG -1.69%98.570.6%$159.39m

Company Profile

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company is headquartered in La Jolla, CA.